← Eichor
Condition: Phosphoric Diester Hydrolases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Phosphoric Diester Hydrolases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors
Phase 1 · 6 location(s) · Janssen Research & Development, LLC · NCT07223125Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and th
Phase N/A · 1 location(s) · Yale University · NCT07488819Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
Phase 2 · 1 location(s) · Tanta University · NCT05575505A Study of JNJ-87890387 for Advanced Solid Tumors
Phase 1 · 6 location(s) · Janssen Research & Development, LLC · NCT06178614PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency
Phase N/A · 14 location(s) · Inozyme Pharma · NCT06302439Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
EARLY_Phase 1 · 1 location(s) · University of Arizona · NCT06643221Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
Phase 2 · 15 location(s) · Mirum Pharmaceuticals, Inc. · NCT07209462COMPERA / COMPERA-KIDS
Phase N/A · 7 location(s) · Technische Universität Dresden · NCT01347216Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization
NA · 1 location(s) · UMC Utrecht · NCT06232889Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05844462The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency
Phase 1 · 7 location(s) · Inozyme Pharma · NCT05734196ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency
Phase 3 · 8 location(s) · Inozyme Pharma · NCT07473973
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.